Truist Financial lowered its price objective on Arthur J. Gallagher & Co., while Cantor Fitzgerald raised its price target. The company also filed a disclosure with the SEC.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial lowered its price objective on Arthur J. Gallagher & Co., while Cantor Fitzgerald raised its price target. The company also filed a disclosure with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arthur J. Gallagher & Co.
insurance brokerage and risk management services company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- Cantor Fitzgerald raised its price target on Texas Instruments shares on July 8, 2026.
- Morgan Stanley and Cantor Fitzgerald raised target prices, while filings detailing stock changes were submitted to the SEC.
- Cantor Fitzgerald raised its price target on Salesforce on September 1, 2026.